Tim Jensen

Medicin og biovidenskab

1. Adalimumab 31%
2. Albumins 59%
3. Aminoglycosides 27%
4. Atrial Heart Septal Defects 29%
5. Bacteria 16%
6. Bilateral Hearing Loss 16%
7. Bone Density 33%
8. Bosentan 35%
9. Bronchitis 29%
10. Cancellous Bone 26%
11. Cardiomyopathies 24%
12. Child 25%
13. Conservative Treatment 22%
14. Diabetic Nephropathies 100%
15. Eisenmenger Complex 38%
16. Endothelin Receptor Antagonists 33%
17. Extracellular Matrix 21%
18. Fibrinolysis 34%
19. Fish Oils 30%
20. Fistula 22%
21. Fontan Procedure 33%
22. Hand Bones 36%
23. Hearing Loss 23%
24. Heart Transplantation 26%
25. Hypoglycemia 24%
26. Insulin 75%
27. Metformin 26%
28. Methotrexate 24%
29. Necrotizing Enterocolitis 30%
30. Pericardial Effusion 29%
31. Placebos 38%
32. Plasminogen Activator Inhibitor 1 36%
33. Plasminogen Activators 24%
34. prothrombin fragment 1 31%
35. prothrombin fragment 2 30%
36. Pulmonary Arterial Hypertension 19%
37. Pulmonary Hypertension 24%
38. Resuscitation 23%
39. Rheumatoid Arthritis 20%
40. ribosomal RNA 12S 40%
41. Septal Occluder Device 17%
42. Sildenafil Citrate 31%
43. Stab Wounds 34%
44. Therapeutics 17%
45. Thorax 28%
46. Tissue Plasminogen Activator 40%
47. Tunica Intima 26%
48. Type 1 Diabetes Mellitus 91%
49. Type 2 Diabetes Mellitus 18%
50. Ventricular Heart Septal Defects 28%